UNSPSC 51142501: Bromocriptine

This classification denotes a neuroprotective agent with the molecular formula C32H40BrN5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3A64E3G5ZO, chemically known as ergotaman-3,6,18-trione, 2-bromo-12-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-, (5.alpha.)- but generally known as bromocriptine, which bears US NIH Compound Identifier 2443. Bromocriptine most often comes in base and mesilate (mesylate) forms.

UNSPSC 51142501 Bromocriptine is a Commodity code that nominally covers a pharmaceutical product used primarily in endocrinology and neurology. State and local procurement activity under this code does not reflect consistent purchasing aligned with the pharmaceutical scope — the three most recent opportunities posted show material misalignment with bromocriptine or any pharmaceutical procurement. Washington County, Oregon solicited a District Attorney's Office Dog; the City of Tucson issued an RFP for athletic training services for fire and police departments; and the City of Tampa's Fire Rescue Department sought medical aid supplies including first aid kits, bandages, and antiseptic products. None of these opportunities involve bromocriptine or pharmaceutical procurement as the code nominally describes.

The recent-opportunities block shows minimal activity directly related to the code's name. The geographic spread across Oregon, Arizona, and Florida suggests only incidental tagging of the bromocriptine code to unrelated services and supplies. No issuing body appears more than once in the available record, and no representative procurement pattern emerges that would inform a business development strategy under this code. State and local procurement under 51142501 shows little relevant recent activity, with the tagged opportunities reflecting apparent metadata misclassification rather than actual bromocriptine purchasing.